Demuris and Newcastle University enter into Funded Collaboration with Morningside Ventures

Focused on the development of novel therapeutics for mitochondrial diseases. Newcastle, UK – 2 August 2019 – The Wellcome Centre for Mitochondrial Research (WCMR) at Newcastle University and Demuris Limited have entered into a collaboration agreement related to the development of novel therapies to treat mitochondrial diseases. This agreement is funded by Morningside Ventures and is …

Demuris and Newcastle University enter into Funded Collaboration with Morningside Ventures Read More »